Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hemophilia Patients Call For US FDA Hearing To Assure Access To Hemlibra

Executive Summary

Patients submit citizen petition in response to Shire's request for preliminary injunction in patent dispute with Genentech, calling it a clear example of 'gaming the system.'


Related Content

Keeping Track: A Fresh Wave Of Approvals
He's Handled More ANDA Cases Than Anyone, And Now He's Retiring: Judge Sleet Reflects On His Career
Hemophilia Community Not 'Choosing A Side' In Hemlibra Litigation
Roche's Hemlibra Priced And Labeled To Beat Competition, Safety Concern


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts